The Effect of Nurse-led Care on Stability Time in Therapeutic Range Ischemic Stroke Patients

Not Applicable

• Conditions: ischaemic stroke.; Transient cerebral ischaemic attacks and related syndromes ,Vascular syndromes of brain in cerebrovascular diseases; G 45 ,G 46

• Registration Number: IRCT2016021626581N1
• Lead Sponsor: Shiraz University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 February 2018

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 80

Inclusion Criteria

Patients with ischemic stroke have been one reason; Patients whose disease is confirmed by a neurologist doctor and refer to warfarin clinics in Specified time range of in the study; Patients under 76 years are allowed to enter the study; Patients who live in shiraz or around the city of Shiraz and refer to clinic in the established days; Patients who are committed to the principles of the laboratory tests are required to use the unit for lab test checking; Patients willing to participate in the study and signed an informed consent form 7 Patients taking warfarin for one month before starting the study
Exclusion criteria: Patients who have to be discontinued warfarin for any reason; Deaths during the study period due to complications from a stroke or other causes; Patients did not provide the necessary cooperation to control their INR during the study period

Exclusion Criteria

Not provided

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
INR. Timepoint: Baseline and then at intervals required. Method of measurement: blood test.

Secondary Outcome Measures

Name	Time	Method
Recurrent stroke and bleeding. Timepoint: At each visit of patients. Method of measurement: question and observation.